FDA, working to tackle pandemic inspection backlog, struggles with foreign oversight and site visits for new drugs
FDA, working to tackle pandemic inspection backlog, struggles with foreign [...]
FDA, working to tackle pandemic inspection backlog, struggles with foreign [...]
Sanofi coughs up $180M to settle Pompe disease royalty payment [...]
AstraZeneca CEO questions mRNA vaccine superiority, raising theory that his [...]
Novartis may have a buyer for $21B generics unit Sandoz: [...]
Sagent Pharmaceuticals recalls injectable seizure med thanks to familiar packaging [...]
EsoCap swallows up VC cash to fuel study of topical [...]
Amgen, Biohaven, Lilly and Teva plowed plenty into marketing migraine [...]
CDC vaccine advisers endorse Pfizer, Moderna COVID boosters for all [...]
FDA asks for 55 years to complete FOIA request on [...]
BioMarin’s dwarfism drug Voxzogo could be its next blockbuster, but [...]